Zivo Bioscience Inc (ZIVO)
7.99
0.00 (0.00%)
USD |
OTCM |
Jun 14, 16:00
Zivo Bioscience Shareholders Equity (Quarterly): -2.269M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -2.269M |
December 31, 2023 | -2.206M |
September 30, 2023 | -1.094M |
June 30, 2023 | -3.145M |
March 31, 2023 | -1.742M |
December 31, 2022 | -0.0106M |
September 30, 2022 | 1.524M |
June 30, 2022 | 3.010M |
March 31, 2022 | 4.584M |
December 31, 2021 | 6.042M |
September 30, 2021 | 7.420M |
June 30, 2021 | 7.333M |
March 31, 2021 | -11.42M |
December 31, 2020 | -11.31M |
September 30, 2020 | -11.09M |
June 30, 2020 | -9.993M |
March 31, 2020 | -9.148M |
December 31, 2019 | -8.338M |
September 30, 2019 | -10.90M |
June 30, 2019 | -11.16M |
March 31, 2019 | -24.70M |
December 31, 2018 | -22.28M |
September 30, 2018 | -21.57M |
June 30, 2018 | -18.84M |
March 31, 2018 | -19.56M |
Date | Value |
---|---|
December 31, 2017 | -16.30M |
September 30, 2017 | -18.04M |
June 30, 2017 | -16.57M |
March 31, 2017 | -15.33M |
December 31, 2016 | -13.62M |
September 30, 2016 | -12.77M |
June 30, 2016 | -11.11M |
March 31, 2016 | -10.12M |
December 31, 2015 | -9.497M |
September 30, 2015 | -8.673M |
June 30, 2015 | -7.954M |
March 31, 2015 | -7.357M |
December 31, 2014 | -6.369M |
September 30, 2014 | -8.043M |
June 30, 2014 | -5.007M |
March 31, 2014 | -4.883M |
December 31, 2013 | -9.594M |
September 30, 2013 | -10.54M |
June 30, 2013 | -8.610M |
March 31, 2013 | -4.877M |
December 31, 2012 | -3.956M |
September 30, 2012 | -3.349M |
June 30, 2012 | -3.142M |
March 31, 2012 | -2.454M |
December 31, 2011 | -2.032M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-11.42M
Minimum
Mar 2021
7.420M
Maximum
Sep 2021
-3.196M
Average
-2.237M
Median
Shareholders Equity (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 0.16M |
Palatin Technologies Inc | 1.579M |
iBio Inc | 24.86M |
Theriva Biologics Inc | 34.12M |
Oragenics Inc | 2.625M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 0.8164M |
Total Liabilities (Quarterly) | 3.085M |
Debt to Equity Ratio | -0.3085 |
Current Ratio | 0.2303 |
Net Debt Paydown Yield | -0.43% |